US Transdermal Patch Market Outlook 2020 - Increase in Demand for Better Therapeutics at Affordable Prices - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "US Transdermal Patch Market Outlook 2020" report to their offering.

Among the newer methodologies for administration of medicines is the use of transdermal approaches, including gels and patches for the treatment of many of the more common ailments. The creation of transdermal delivery systems has been one of the most important innovations, offering a number of advantages over the oral route.

The market for transdermal products has skyrocketed since its innovation and is likely to continue for the foreseeable future. An increasing number of Transdermal Drug Delivery (TDD) products continue to deliver real therapeutic benefit to patients around the world. The FDA approved a total of 32 transdermal products over the past 20 years, the majority of which use passive transport that allows the drug to be continually absorbed into the skin via natural processes.

Increase in demand for better therapeutics at affordable prices is expected to be the main factor behind their growth in US market. Improved material science, advanced manufacturing capabilities and high acceptance rates will further propel growth in this segment. However, some immediate issues like lesser coverage of indications have yet to be overcome in coming years. Another issue is technology related, which has definitely improved, but needs to be improved in order to come forth with diseases like HIV infection. Overall, transdermal patch market in US is expected to grow continuously reflecting optimistic future.

Companies Mentioned:

  • 3M Pharmaceuticals
  • Acrux
  • Agile Therapeutics
  • Allergan
  • ANI Pharmaceuticals
  • Antares Pharma
  • Bayer HealthCare Pharmaceuticals
  • Corium International
  • Chase Pharmaceuticals
  • DURECT Corporation
  • Endo Pharmaceuticals
  • Fempharm
  • Hisamitsu Pharmaceutical
  • Immune Pharmaceuticals
  • Imprimis Pharmaceuticals
  • Ipsen Bioscience
  • Johnson & Johnson
  • LaSalle Laboratories
  • (20+ Others)

Key Topics Covered:

1. Introduction to Transdermal Patch

2. Classification of Transdermal Patches

3. Why There Exist Need for Transdermal Patches?

4. Mechanism of Transdermal Patch Drug Delivery

5. Transdermal Patch v/s Traditional Drug Delivery Methods

6. US Transdermal Patch Market Overview

7. Generic & Branded Transdermal Patches

8. Value Chain Analysis for Transdermal Patch Market

9. US Transdermal Patch Contract Manufacturing Organization (CMO)

10. US Transdermal Patch Market Opportunity Assessment

11. US Transdermal Patch Market Dynamics

12. US Transdermal Patch Market Future Prospects

13. US Transdermal Patch Clinical Pipeline by Company, Indication & Phase

14. Marketed Transdermal Patch Clinical Insight by Company & Indication

15. Discontinued & No Development Reported in US Transdermal Patch Clinical Pipeline

16. Competitive Landscape

For more information visit http://www.researchandmarkets.com/research/lwfp5z/us_transdermal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Transdermal and Transmucosal Drug Delivery

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Transdermal and Transmucosal Drug Delivery